203
Views
8
CrossRef citations to date
0
Altmetric
Original Articles

Preparation of ultrafine poly(methyl methacrylate-co-methacrylic acid) biodegradable nanoparticles loaded with ibuprofen

, , &
Pages 1126-1138 | Received 18 Jan 2016, Accepted 26 Apr 2016, Published online: 12 May 2016

References

  • Sonje A, Chandra A. Comprehensive review on Eudragit polymers. Int. Res. J. Pharm. 2013;4:71–74.10.7897/2230-8407
  • Dai J, Nagai T, Wang X, et al. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A. Int. J. Pharm. 2004;280:229–240.10.1016/j.ijpharm.2004.05.006
  • Abdul Majeed AB, Pereira REV, Julianto TB, et al. Proceedings of the Nanoscience and Nanotechnology (ICCON); 2010 Feb 22; Sydney, NSW.
  • Liu Y, Fang Z, Chen Y, et al. The pharmacokinetic profile of freeze-dried cyclosporine A-Eudragit S100 nanoparticle formulation in dogs. Nano Biomed. Eng. 2011;3:53–56.
  • Yoo JW, Giri N, Lee CH. pH-sensitive Eudragit nanoparticles for mucosal drug delivery. Int. J. Pharm. 2011;403:262–267.10.1016/j.ijpharm.2010.10.032
  • Hu D, Liu L, Chen W, et al. A novel preparation method for 5-aminosalicylic acid loaded Eudragit S100 nanoparticles. Int. J. Mol. Sci. 2012;13:6454–6468.10.3390/ijms13056454
  • Prakash SEL, Manavalan R. Development, characterization and/toxicity evaluation of nanoparticles of andrographolide. Int. J. Pharm. Pharm. Sci. 2012;4:497–501.
  • Subramanian L, Ganesan V, Venkateshan N, et al. Design, formulation and evaluation of ofloxacin nanoparticles. Int. J. Biol. Pharm. Res. 2012;3:659–662.
  • Coco R, Plapied L, Pourcelle V, et al. Drug delivery to inflamed colon by nanoparticles: comparison of different strategies. Int. J. Pharm. 2013;440:3–12.10.1016/j.ijpharm.2012.07.017
  • Sutar PS, Joshi VG. Gemcitabine loaded PLGA nanoparticles – An approach for colorectal cancer. Univers. J. Pharm. 2013;2:135–141.
  • Vutpala S, Sailaja AK. Preparation and characterisation of ibuprofen loaded polymeric nanoparticles by solvent evaporation technique. Int. J. Pharm. Pharm. Sci. 2014;6:416–421.
  • des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Controlled Release. 2006;116:1–27.10.1016/j.jconrel.2006.08.013
  • Elsabahy M, Wooley KL. Design of polymeric nanoparticles for biomedical delivery applications. Chem. Soc. Rev. 2012;41:2545–2561.10.1039/c2cs15327k
  • Tita B, Fulias A, Bandur G, et al. Thermal stability of ibuprofen. Kinetic study under non-isothermal conditions. Rev. Roum. Chim. 2010;55:553–558.
  • Saade H, Barrera C, Espinoza A, et al. Ultrafine nanoparticles of ibuprofen-poly(methyl methacrylate) by a polymerization-loading method. Drug Delivery Lett. 2013;3:54–60.10.2174/2210304x11303010008
  • Saade H, Rodríguez H, Cepeda JA, et al. Semicontinuous heterophase polymerization as a tool for preparing ultrafine nanoparticles of ibuprofen-poly(methyl methacrylate). Nano. 2014;9:1450060–1450068.10.1142/S179329201450060X
  • Irani RR, Callis CF. Particle size: measurement, interpretation and application. New York, NY: Wiley; 1963.
  • Evonik Industries [ Internet]. [Cited 2016 Jan 13]. Available from: http://eudragit.evonik.com/product/eudragit/en/products-services/eudragit-products/enteric-formulations/s-100.
  • Brandrup J, Immergut GH, Grulke EA. Polymer handbook. 4th ed. New York, NY: Wiley; 2003.
  • Ramírez AG, López RG, Tauer K. Studies on semibatch microemulsion polymerization of butyl acrylate: influence of the potassium peroxodisulfate concentration. Macromolecules. 2004;37:2738–2747.10.1021/ma030218g
  • Smith WV, Ewart RH. Kinetics of emulsion polymerization. J. Chem. Phys. 1948;16:592–599.10.1063/1.1746951
  • Krackeler JJ, Naidus H. Particle size and molecular weight distributions of various polystyrene emulsions. J. Polym. Sci. Part C: Polym. Symp. 1969;27:207–235.
  • Arzamendi G, Asua JM. Monomer addition policies for copolymer composition control in semicontinuous emulsion copolymerization. J. Appl. Polym. Sci. 1989;38:2019–2036.10.1002/app.1989.070381106
  • Pérez-García MG, Torres EV, Ceja I, et al. Semicontinuous heterophase copolymerization of styrene and acrylonitrile. J. Polym. Sci. Part A: Polym. Chem.. 2012;50:3332–3339.10.1002/pola.v50.16
  • News Medical [ Internet]. [Cited 2016 Jan 13]. Available from: http://www.news-medical.net/whitepaper/20141218/Overview-of-Key-Principles-of-Dynamic-Light-Scattering.aspx.
  • Davidson JA, Macosko CW, Collins EA. Latex particle size analysis: I. J. Colloid Interface Sci. 1967;25:381–388.10.1016/0021-9797(67)90044-6
  • Dubernet C, Rouland JC, Benoit JP. Ibuprofen-loaded ethylcellulose microspheres: analysis of the matrix structure by thermal analysis. J. Pharm. Sci. 1991;80:1029–1033.10.1002/jps.2600801106
  • Otto DP, de Villiers MM. Why is the nanoscale special (or not)? Fundamental properties and how it relates to the design of nano-enabled drug delivery systems. Nanotechnol. Rev. 2013;2:171–199.
  • Shoaib MH, Tazeen J, Merchant HA, et al. Evaluation of drug release kinetics from ibuprofen matrix tablets using HPMC. Pak. J. Pharm. Sci. 2006;19:119–124.
  • Ritger PL, Peppas NA. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J. Controlled Release. 1987;5:23–36.10.1016/0168-3659(87)90034-4
  • Ritger PL, Peppas NA. A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J. Controlled Release. 1987;5:37–42.10.1016/0168-3659(87)90035-6
  • Arora G, Malik K, Singh I, et al. Formulation and evaluation of controlled release matrix mucoadhesive tablets of domperidone using Salvia plebeian gum. J. Adv. Pharm. Technol. Res. 2011;2:163–169.
  • Perumal D, Dangor CM, Alcock RS, et al. Effect of formulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres. J. Microencapsulation. 1999;16:475–487.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.